WO2025132815 - NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME
National phase entry is expected:
Publication Number
WO/2025/132815
Publication Date
26.06.2025
International Application No.
PCT/EP2024/087441
International Filing Date
19.12.2024
Title **
[English]
NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME
[French]
NOUVELLES NUCLÉASES CAS ET POLYNUCLÉOTIDES CODANT POUR CELLES-CI
Applicants **
NOVOZYMES A/S
Inventors
WIRTH, Nicolas
SAENZ AUSEJO, Carmen
SALOMON, Jesper
GJERMANSEN, Morten
AZMI, Ishara
Priority Data
63/612,593
20.12.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2936 | |
| EPO | Filing, Examination, Granting | 11881 | |
| Japan | Filing, Examination, Granting | 2172 | |
| South Korea | Filing, Examination, Granting | 2039 | |
| USA | Filing, Examination, Granting | 6840 |
Total:
25,868
Contact Us
Abstract[English]
The present invention relates to novel Cas nucleases and polynucleotides encoding the same. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides and Cas nuclease, as well as fusion polypeptides, gene editing methods, methods of producing the Cas nuclease, formulations comprising the Cas nuclease, and use of the Cas nuclease.[French]
La présente invention concerne de nouvelles nucléases Cas et des polynucléotides codant pour celles-ci. L'invention concerne également des constructions d'acides nucléiques, des vecteurs et des cellules hôtes comprenant les polynucléotides et la nucléase Cas, ainsi que des polypeptides de fusion, des procédés d'édition de gènes, des procédés de production de la nucléase Cas, des formulations comprenant la nucléase Cas, et l'utilisation de la nucléase Cas.